PT  - JOURNAL ARTICLE
AU  - Ji-Yeon Kim
AU  - Minsun Baek
AU  - Sooyong Lee
AU  - Sung-Ok Kim
AU  - Mi-Sook Dong
AU  - Bok-Ryang Kim
AU  - Dong-Hyun Kim
TI  - Characterization of the Selectivity and Mechanism of Cytochrome P450 Inhibition by Dimethyl-4,4′-dimethoxy-5,6,5′,6′-<br/>dimethylenedioxybiphenyl-2,2′-dicarboxylate
DP  - 2001 Dec 01
TA  - Drug Metabolism and Disposition
PG  - 1555--1560
VI  - 29
IP  - 12
4099  - http://dmd.aspetjournals.org/content/29/12/1555.short
4100  - http://dmd.aspetjournals.org/content/29/12/1555.full
SO  - Drug Metab Dispos2001 Dec 01; 29
AB  - In vitro studies with human liver microsomes and cytochrome P450 (P450) prototype substrates were performed to characterize the selectivity and mechanism of inhibition of P450 by dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylenedioxybiphenyl-2,2′-dicarboxylate (DDB). DDB was found to be a strong inhibitor of testosterone 6β-hydroxylation activity (CYP3A4) with aKi value of 0.27 ± 0.21 μM. At higher concentrations, DDB marginally inhibited caffeineN3-demethylation (CYP1A2), diclofenac 4′-hydroxylation (CYP2C9), and dextromethorphanO-demethylation (CYP2D6) activities, but this compound had no effect on CYP2A6-, CYP2C19-, and CYP2E1-mediated reactions. Spectral analysis indicated that the formation of metabolite-P450 complex having absorbance at 456 nm was concentration-dependent; 5 to 33% of the total P450 was complexed in rat and human liver microsomes after a 5-min incubation with DDB. In addition, microsomal incubations with DDB in the presence of NADPH resulted in a loss of spectral P450 content, which was restored after adding K3Fe(CN)6. This complex formation resulted in a time-dependent loss of CYP3A-catalyzed marker activity (testosterone 6β-hydroxylation) in human liver microsomes. The inhibition was only partially restored upon dialysis. These results collectively suggest that formation of a metabolite-CYP3A complex with DDB was responsible for the CYP3A-selective time-dependent loss of catalytic function of CYP3A. The American Society for Pharmacology and Experimental Therapeutics